Kendall Court Capital Partners has announced a first closing on $35m for its debut Asian mezzanine fund. The fund has a final target of $75m.
A new study shows views among limited partners regarding the relative prospects of buyout and venture funds are strongly polarised.
Washington DC-based Paladin Capital Group’s second fund will focus on early- and mid-stage venture capital investments, although the firm will consider buyout opportunities.
Herald Ventures, run by UK technology investor Katie Potts, has held a first closing on an early-stage technology, telecom and media fund with a £40m target.
The newly-independent Dutch private equity firm, formerly known as NeSBIC, has closed its second fund ahead of a €200m target.
Emerging Markets Partnership (EMP), the Central Europe-focused private equity house, has agreed to sell its 39 percent stake in Polish broadband operator Aster City Cable to Hicks, Muse, Tate & Furst.
Dallas-based buyout shop Hicks, Muse, Tate & Furst will acquire Regency Gas Services, a US gas gathering, processing and transmission company.
The New York middle-market firm has announced the sale of Floral Plant Growers to Blue Point Capital.
Bain Capital Ventures’ second fund follows its 2001 same-sized vehicle, which is close to being fully invested.
The Pittsburgh-based financial services giant’s announcement of its third and final close on its $56.4m fund comes a month after Mellon’s venture arm announced it would cease making new investments.
The Minneapolis-based firm has completed the $200m sale of the protective case and flashlight maker to New York- and San Francisco-based Behrman Capital.
New York private equity firm Palladium Equity has garnered its largest commitment from Spanish bank Banco Bilbao Vizcaya Argentaria, will invest in US companies linked to the Hispanic community.
Proof of a still burgeoning secondaries market comes with Greenpark Capital’s announcement of the final close of its €350m second fund.
The European private equity firm has acquired a 46 percent stake in a Dutch mail-order pharmacy company from 3i and other shareholders.
The San Francisco-based mid-market buyout shop closes its largest fund yet, which will focus on life sciences, business services and industrial technologies.